Benefit of IQP-VV-102 in Reducing Postprandial Glucose Level in Overweight Caucasian Subjects

Inclusion Criteria: * Caucasian * BMI between ≥ 25 and \< 30 kg/m2 * Normal to prediabetic biomarkers: FBG 3.9-6.9 mmol/L / 70-125mg/dL and HbA1c 4-6.4% * Willing to take test meal and adhere to consumptions of pre-prepared meals supplied (controlled by subject diary) * Willing to maintain same level of physical activity during the study * Willing to arrive at the study site with the same, non-strenuous means of transportation during the study * Negative pregnancy testing (beta hCG) for women of childbearing potential during screening * Women of child-bearing potential have to agree to use appropriate birth control methods during the study period * Written informed consent of the subject to participate is a prerequisite for study participation Exclusion Criteria: * Known sensitivity to L-arabinose and grape marc extracts, or any sources of the active ingredients and excipients * Use of medications or dietary supplements that may influence body weight 4 weeks, and gastrointestinal functions 2 weeks prior to enrolment and during the study * Use of anti-diabetic medication * Strenuous exercise within one day prior to blood glucose sampling (including screening). * History of bariatric surgery, small bowel resection, or extensive bowel resection * Difficult veins * Recent blood donation in the last 1 month prior to study * Pregnancy or nursing * Clinically relevant excursions of safety parameters * Any other serious condition or disease that renders subjects ineligible * Smoking * Exceeding safe alcohol consumption (men: ≥ 21 units/week; women: ≥ 14 units/week) and any alcohol consumption within 24 hours before venous blood glucose sampling * All vegetarians and subjects with self-reported diet high in fat or protein * Subjects are not able to communicate with local study staff * Recent antibiotic and cortisone use up to one week and during the study * Participation in another study during the last 30 days of the screening visit (V1)